1. Introduction {#sec1}
===============

*Exocarpium Citri Grandis* (ECG, Huajuhong in Chinese), the dried unripe or ripe fruit peel of *Citrus grandis*Osbeck or *Citrus grandis* Osbeck var. tomentosa Hort, is a well-known traditional Chinese medicine \[[@B1]\]. Since it has been proved to possess the effects of clearing heat and expectoration, regulating the flow of vital energy, and stimulating appetite, ECG has been employed in the treatment of coughing, dyspepsia, nausea, itching of throat, and so forth, which makes it widely used in practice for a long time in China \[[@B2]--[@B4]\]. ECG from *Citrus grandis* "tomentosa" (Maojuhong in Chinese) is generally acknowledged to be of better quality than *Citrus grandis (L.)* Osbeck (Guangjuhong in Chinese). ECG from Huazhou city, Guangdong province, whose plant origin is *Citrus grandis* "tomentosa," is usually considered as the genuine medicinal materials \[[@B5]\].

Main phytochemical constituents of ECG were reported as volatile oil, flavonoids, coumarins, and polysaccharides \[[@B6]--[@B8]\], among which volatile composition has been investigated worldwide and the essential oil from ECG was broadly used as aroma flavor in food products and flavoring agents to mask the unpleasant tastes of drugs in pharmaceutical industries \[[@B9]\]. Alkene is the major volatile compounds of ECG typically including limonene, pinene, and myrcene \[[@B10]\]. The amount of volatile components of ECG plays a significant role in the quality of crude drug. For example, limonene, one of the principal components of ECG, possesses the antibacteria, anti-inflammatory, and expectorant activity \[[@B11]\].

Traditionally, the extraction of volatile components from ECG relied largely on steam distillation (SD) and solvent extraction (SE) at both analytical and preparative levels. However, there have been rare studies on the comparison of volatile components from ECG by different extracting methods. The innovative solid-phase microextraction (SPME) was more rapid, sensitive, and solvent-free compared to traditional methods. SPME was first introduced by Professor Pawliszyn and his coworkers in 1990s and has been extensively adopted in air, water, soil, and food analysis \[[@B12]\]. Typically, the analytes are extracted from a gaseous or liquid sample by absorption in direct-immerse solid-phase microextraction (DI-SPME) or adsorption on headspace solid-phase microextraction (HS-SPME) with a thin polymer coating being fixed to the solid surface of a fiber in an injection needle \[[@B13]\]. Since HS-SPME was nonpolluting to fiber compared with DI-SPME, it was eventually chosen to be compared with SD and SE. Gas chromatography-mass spectrometry (GC/MS) enables compound identification by comparing the obtained mass spectra of the analytes with those of authentic standards from the National Institute of Standards and Technology (NIST) and comparing the retention indices (RIs) with those reported by a previous available study.

The work stated here is aiming to fill in the blank field through the analysis of volatile components from ECG extracted by SD, HS-SPME, and SE methods individually. GC/MS was employed to identify compounds in the extracted samples. This would reveal how many volatile components they were able to extract and consequently help evaluate the extraction efficiency in addition to sample amount and extraction duration.

2. Materials and Methods {#sec2}
========================

2.1. Materials and Reagents {#sec2.1}
---------------------------

ECG (Huazhou, Guangdong, China) was purchased from Caizhilin pharmacy and was authenticated by Dr. Xu. It was ground to a certain particle size (60 meshes) for the follow-up pretreatments. Anhydrous sodium sulphate was provided by Guangzhou Chemical Reagent Factory (Guangzhou, China). Anhydrous ethyl alcohol, diethyl ether, and *n-*hexane were analytically pure and purchased from Damao Chemical Reagents Works (Tianjin, China).

2.2. Steam Distillation Procedure {#sec2.2}
---------------------------------

Thirty-six grams of ECGpowder was suspended in 300 mL of water to collect the volatile oil by steam distillation for 5 h according to Appendix XD of Chinese Pharmacopoeia \[[@B14]\]. A little drop of kelly green oil was diluted with 1 mL of  *n*-hexane and dehydrated by adding adequate anhydrous sodium sulphate. The solution was then centrifuged for 5 minutes to obtain the volatile oil sample.

2.3. HS-SPME Procedure {#sec2.3}
----------------------

Divinylbenzene/carboxen/polydimethylsiloxane (DVB/CAR/PDMS, 50/30 *μ*m), which was designed for analytes with a broad range of polarities (suitable for C~2~--C~20~ range) \[[@B15], [@B16]\], was purchased from Supelco (Supelco Park Bellefonte, Pennsylvania, USA). It was attached in a SPME holder (Supelco) and used to achieve absorption of volatile components as full as possible from ECG for qualitative analysis. The fiber was conditioned prior to use by inserting it to the GC injection port at 280°C for 2 h under 1 mL/min of gas flow. ECG powder (0.2 g) and anhydrous sodium sulphate (0.2 g) were mixed in a 15 mL flat bottom headspace vial which was sealed with a gray butyl headspace stopper and a 20 mm unlined crimp cap using a crimper. SPME fiber was pushed out and exposed to the headspace of the vial for the absorption of the volatile components, with the vial heated at sustained 80°C for 40 min. Finally, the fiber was removed from the vial and analytes were desorbed by exposing the fiber in the injection port of a GC/MS at 250°C for 2 min.

2.4. Diethyl Ether Extraction {#sec2.4}
-----------------------------

Three grams of ECG powder was extracted using diethyl ether (1 : 10, w/v) for three times (15 minutes each time) with the assistance of ultrasonic. The obtained turbid solution was filtrated and the solvent of filtrate was removed by rotary evaporation under reduced pressure. Then the extractum was diluted with 1 mL of anhydrous ethyl alcohol:  *n*-hexane (1 : 1, v/v) and was filtered through a 0.22 *μ*m membrane filter. 1 *μ*L of subsequent filtrate was injected to GC/MS for analysis.

2.5. GC-MS Analysis and Identification for Volatile Components {#sec2.5}
--------------------------------------------------------------

The analysis for volatiles in ECG was performed by the GC/MS instrument (Thermo Electron Corporation, USA) equipped with a Finnigan Trace DSQ and an electron impact (EI) ion source. The analytes were separated on a DB-5MS capillary column (30 m × 0.25 mm × 0.25 *μ*m; Agilent, USA) coated with phenyl arylene polymer. The oven temperature program was as follows: 50°C initially for 1 minute, increased to 145°C at 5°C/min, increased to 175°C at 7°C/min, increased to 195°C at 5°C/min, and then ramped to 250°C at 3°C/min; 250°C was maintained for 10 min. High pure helium (99.999%) was the carrier gas set at a constant flow rate of 1 mL·min^−1^. The injection port, transfer line, and ion source temperatures were all set at 250°C. 70 eV of EI was adopted, and the mass scanning range was set from 50 to 650 amu in full scan. The injection was performed by split mode with a split ratio of 10 : 1. Solvent delay time was set for 3 min for all samples generated by different methods. Xcalibur 2.0 workstation was used to process data.

Most volatile components extracted from ECG were identified by comparing the RIs and comparing the obtained mass spectra of the analytes with those of authentic standards from the NIST libraries (2005) and with the mass spectra published previously \[[@B7], [@B10], [@B17]\]. RIs were determined by analyzing a solution containing the homologous series of normal alkanes (C~7~--C~22~) and then calculated as described by van Den Dool and Kratz \[[@B18]\]. Peak areas of all components were calculated by Xcalibur 2.0, and relative amounts (RAs) of volatile compounds were calculated on the basis of peak-area ratios.

3. Results and Discussion {#sec3}
=========================

3.1. Analysis of the Volatile Compounds in ECG {#sec3.1}
----------------------------------------------

The volatile compounds in ECG sample were extracted by HS-SPME, followed by desorption and analysis with GC-MS. The volatile compounds in ECG were also extracted by SD and SE method. The typical total ion chromatograms of the extracts obtained by SD, HS-SPME, and SE were shown in [Figure 1](#fig1){ref-type="fig"} and indicated the differences in volatiles composition among different methods. A total of 81 compounds extracted by SD, HS-SPME, and SE were identified and listed in [Table 1](#tab1){ref-type="table"}, where the RIs and RAs of volatile compounds in ECG were presented. As detailed in [Table 1](#tab1){ref-type="table"}, 77, 56, and 48 compounds were identified by SD-GC/MS, HS-SPME-GC/MS, and SE-GC/MS methods, respectively, and HS-SPME-GC/MS method shared 56 and 34 compounds in common with SD-GC/MS and SE-GC/MS, respectively. The families of detected volatiles in ECG contained terpenes, alcohols, esters, organic acids, ketones, and aldehydes, whose contents by different methods were described in [Figure 2](#fig2){ref-type="fig"}. In spite of the three methods, terpenes constituted the most dominant chemical group present in ECG volatiles (39.98\~57.81%). It was notable that germacrene-D (the richest terpenoid in ECG volatiles) possessed a larger proportion in ECG, as compared with the previous reports \[[@B11], [@B19]\]. Second to terpenes, alcohols were another rich common class in ECG volatiles by SD and HS-SPME, whereas acids were the second most constituent in diethyl ether extract. As presented in [Table 1](#tab1){ref-type="table"} and [Figure 2](#fig2){ref-type="fig"}, SD was proved to be efficient in extracting terpenes (57.81%) and alcohols (19.61%), the two families with a relative high content in ECG; SE resulted in a relative high percentage of terpenes (39.98%), acids (16.97%), esters (14.82%), and alcohols (14.76%) with diethyl ether as a solvent. In HS-SPME, the main volatiles using DVB/CAR/PDMS fiber were terpenes (55.47%) and alcohols (29.29%). The results of the three extraction methods indicated that the major volatiles in ECG were terpenes, alcohols, acids, and esters.

SD extracts (yield: 0.89%; yellow-green oil) showed higher proportions of terpenes than those by SPME and SE, not only in the category (38) but also in the relative amount (57.81%). Germacrene-D (13.28%) and limonene (11.77%) were the most two enriched ones followed by 2,6,8,10,14-hexadecapentaene, 2,6,11,15-tetramethyl-, (E,E,E)- (6.54%), *δ-*cadinene (4.73%), *γ*-terpinene (3.75%), *γ-*muurolene (2.87%), *trans*-caryophyllene (2.63%), and *β*-myrcene (2.63%). The major alcohols by SD included *trans-*nerolidol (4.03%), geranyl linalool (3.54%), and *α*-cadinol (2.61%). Acids, mainly hexadecanoic acid (4.79%), could be effectively extracted by SD.

As a moderate and simple extraction method, SE with diethyl ether was also carried out for the extraction of constituents from ECG, yielding 0.11 g of yellow-green viscous concentrates. In the SE extract, terpenes were still the most abundant constituents but much less in category (17) and relative amount (39.98%) than those obtained by the other two methods, which might be due to the evaporation step during the SE process that might lead to the loss of the most volatile components. However, certain high molecular-weight compounds (mainly acids) that did not contribute to the aroma, such as fatty acids, were extracted in large amount (16.97%). Amongst the less volatile components, the relative amount of hexadecanoic acid reached 11.7%, followed by *α*-linoleic acid (4.14%).

The major components of the volatile components extracted by HS-SPME were terpenes (55.47%), which were in accordance with those by SD in categories and percentages. The terpenes by HS-SPME mainly contained germacrene-D (11.36%), 2,6,8,10,14-hexadecapentaene, 2,6,11,15-tetramethyl-, (E,E,E)- (8.49%), limonene (7.49%), *trans*-caryophyllene (5.94%), and so forth. HS-SPME-GC/MS enabled the detection of most odour active compounds in ECG and was indicated to be much richer in alcohols (29.29%) than those obtained by SD (19.61%) and SE (14.76%). The alcohols extracted by HS-SPME were abundant in *trans*-nerolidol (9.9%), terpinen-4-ol (3.42%), and geranyl linalool (3.31%). Nevertheless, compared to SE, HS-SPME was of poor capacity in extracting acids (1.06%) because of the poor volatility and affinity to the fiber of those compounds.

As mentioned above, among all the compounds identified, germacrene-D, 2,6,8,10,14-hexadecapentaene, 2,6,11,15-tetramethyl-, (E,E,E)-, *trans*-nerolidol, and *trans-*caryophyllene accounted for a quite great proportion in total quantity (expressed as RA%). [Figure 3](#fig3){ref-type="fig"} showed a clear comparison of the RA% values for the eight target compounds extracted by the three methods. The present HS-SPME-GC/MS method obtained much higher RA% for *trans-*nerolidol and*trans-*caryophyllene but lower RA% values for germacrene-D and geranyl linalool. On one hand, this was due to the difference of affinity of the fiber to those compounds. On the other hand, HS-SPME is a relative temperate extraction way especially for those thermally sensitive compounds which could be partly or completely lost during the long-time heating by SD. The comparison among the results by HS-SPME, SD, and SE methods showed that HS-SPME was better for more thermally sensitive volatile compounds, SD for volatile compounds, and SE for high molecular weight compounds. On the whole, the profiles obtained by HS-SPME were similar to those by SD, which revealed that HS-SPME manifested good affinity to principal volatile components of ECG.

3.2. Comparison of the Extraction Parameters among the Three Methods {#sec3.2}
--------------------------------------------------------------------

In addition to the amounts of volatile components extracted by the above three methods (i.e., SD, HS-SPME, and SE), other parameters in terms of extraction time, solvent volume, and economic cost about the three extraction methods were also compared. The results were detailed in [Table 2](#tab2){ref-type="table"}. Although it was relatively expensive to purchase the fiber, HS-SPME presented significant advantages over the other two methods in qualitative analysis at analytical level. First, HS-SPME showed significant environmental friendliness compared to SD and SE since it was solvent-free. Then, HS-SPME was clearly fast and efficient (40 min) while 5 h was required for SD and 45 min for SE. Last but not the least, the amount of the plant material used for the HS-SPME analysis was much smaller than that for the SD (36 g) and SE (3 g). The above results indicated that HS-SPME had remarkable advantages in time, plant material, and solvent consuming in rapid extraction and analysis, as compared to the other two methods. However, HS-SPME was inferior to SD and SE in quantitative analysis since it was unattainable for the yield of the crude extract from ECG.

As one of the most classical extraction techniques for essential oil, SD did not discriminate against most volatiles in the extraction even though it required a long time to accomplish the procedure. Moreover, compared with HS-SPME, SD and SE were more flexible and competent for preparative extraction both in small batches and in large scale.

4. Conclusions {#sec4}
==============

In this study, three extraction technologies (SD, HS-SPME, and SE) coupled with GC/MS were compared in terms of the category and the content of volatile components extracted from ECG and other extraction parameters. 77, 56, and 48 volatile components, belonging mainly to terpenes, alcohols, acids, and esters, were extracted and successfully identified, respectively. Germacrene-D and limonene were the two major volatiles in ECG. Amongst the three extraction methods, SD gave a relatively entire profile of volatiles in ECG by long-time extraction; SE enabled the analysis of low volatility and high molecular weight compounds. Both of them were competent for extraction of volatiles at analytical and preparative level. HS-SPME could effectively and rapidly extract principle volatile components from ECG at analytical level, giving similar profiles of volatiles to those by SD. The study indicated that HS-SPME was suitable for rapid qualitative analysis for the volatile components in ECG. This technique could be used for the routine quality control analysis of medicinal plants at analytical level.
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![GC/MS total ion chromatograms of ECG by (a) steam distillation, (b) headspace solid-phase microextraction, and (c) solvent extraction.](JAMC2013-918406.001){#fig1}

![Comparison of volatile categories in ECG by three extraction methods.](JAMC2013-918406.002){#fig2}

![Comparison of the relative amount of the eight target compounds by SD, HS-SPME, and SE methods. (1) Germacrene-D; (2) 2,6,8,10,14-hexadecapentaene, 2,6,11,15-tetramethyl-, (E,E,E)-; (3) limonene; (4) *trans*-nerolidol; (5)*trans*-caryophyllene; (6) *δ*-cadinene; (7) *β*-cubebene; (8) geranyl linalool.](JAMC2013-918406.003){#fig3}

###### 

Volatile compounds of ECG identified by GC/MS.

  No.   RI^a^   Name                                                                    ID^b^    CAS no.      Relative amount (%)^c^           
  ----- ------- ----------------------------------------------------------------------- -------- ------------ ------------------------ ------- -------
  1     773     1,3,5-Trioxepane                                                        MS, RI   5981-6-6     ---                      ---     1.37
  2     834     Furfural                                                                MS, RI   98-01-1      0.05                     ---     ---
  3     937     *α*-Pinene                                                              MS, RI   7785-70-8    0.19                     ---     ---
  4     960     Heptanol                                                                MS, RI   53535-33-4   ---                      ---     0.94
  5     981     *β-*Pinene                                                              MS, RI   18172-67-3   0.27                     0.1     ---
  6     989     *β-*Myrcene                                                             MS, RI   123-35-3     2.63                     1.51    0.34
  7     1004    *α-*Phellandrene                                                        MS, RI   99-83-2      0.15                     ---     ---
  8     1018    *α*-Terpinene                                                           MS, RI   99-86-5      0.14                     ---     ---
  9     1022    *o-*Cymene                                                              MS, RI   527-84-4     0.47                     ---     ---
  10    1030    Limonene                                                                MS, RI   5989-27-5    11.77                    7.49    0.25
  11    1045    *trans*-*β*-Ocimene                                                     MS, RI   3779-61-1    0.08                     0.05    ---
  12    1058    *γ-*Terpinene                                                           MS, RI   99-85-4      3.75                     1.33    0.23
  13    1073    *cis*-Linalool oxide                                                    MS, RI   15249-34-0   1.76                     1.84    1.05
  14    1082    *α-*Terpinolene                                                         MS, RI   586-62-9     0.35                     ---     ---
  15    1086    *trans*-Linalool oxide                                                  MS, RI   34995-77-2   0.67                     0.86    0.52
  16    1090    *p-*Cymenene                                                            MS, RI   1195-32-0    0.11                     ---     0.1
  17    1102    Linalool                                                                MS, RI   78-70-6      0.52                     0.35    ---
  18    1114    Nonane, 4-ethyl-5-methyl-                                               MS, RI   1632-71-9    ---                      ---     0.19
  19    1140    Cosmene                                                                 MS, RI   460-01-5     0.04                     ---     0.3
  20    1175    Terpinen-4-ol                                                           MS, RI   20126-76-5   1.2                      3.42    0.69
  21    1190    *α-*Terpineol                                                           MS, RI   98-55-5      0.91                     1.47    0.4
  22    1206    Decanal                                                                 MS, RI   112-31-2     0.1                      0.05    ---
  23    1239    Carvone                                                                 MS, RI   99-49-0      0.05                     0.11    ---
  24    1290    Thymol                                                                  MS, RI   89-83-8      0.04                     0.32    ---
  25    1299    Carvacrol                                                               MS, RI   499-75-2     0.05                     0.37    ---
  26    1306    Undecanal                                                               MS, RI   112-44-7     0.04                     0.07    ---
  27    1335    *ο*-Elemene                                                             MS, RI   3242-08-8    0.15                     1.06    ---
  28    1339    *δ-*Elemene                                                             MS, RI   20307-84-0   0.69                     0.73    0.28
  29    1351    *α-*Cubebene                                                            MS, RI   17699-14-8   0.23                     0.31    0.14
  30    1362    *cis-*Geranyl acetate                                                   MS, RI   141-12-8     0.21                     0.41    0.1
  31    1376    Ylangene                                                                MS, RI   14912-44-8   0.21                     0.25    0.12
  32    1378    *α-*Copaene                                                             MS, RI   3856-25-5    0.7                      0.66    0.45
  33    1395    *β*-Elemene                                                             MS, RI   515-13-9     0.72                     0.74    0.59
  34    1411    Dodecanal                                                               MS, RI   112-54-9     0.25                     0.2     0.09
  35    1417    *trans*-Caryophyllene                                                   MS, RI   87-44-5      2.63                     5.94    2.23
  36    1420    *β-*Cubebene                                                            MS, RI   13744-15-5   0.95                     3.26    0.81
  37    1433    *β-*Aromadendrene                                                       MS, RI   25246-27-9   0.23                     0.15    ---
  38    1451    Isoledene                                                               MS, RI   NA^d^        0.23                     1.06    ---
  39    1455    1,4,7,-Cycloundecatriene, 1,5,9,9-tetramethyl-, Z,Z,Z-                  MS, RI   NA^d^        0.36                     0.28    ---
  40    1463    2-Isopropenyl-4a,8-dimethyl-1,2,3,4, 4a,5,6,7-octahydronaphthalene      MS, RI   NA^d^        0.28                     0.75    ---
  41    1480    *γ-*Muurolene                                                           MS, RI   30021-74-0   2.87                     2.11    1.68
  42    1486    Germacrene-D                                                            MS, RI   23986-74-5   13.28                    11.36   14.2
  43    1494    *α-*Muurolene                                                           MS, RI   10208-80-7   1.07                     1.92    1.12
  44    1511    *γ-*Cadinene                                                            MS, RI   39029-41-9   1.62                     1.35    1.2
  45    1528    *δ-*Cadinene                                                            MS, RI   483-76-1     4.73                     3.25    2.71
  46    1536    Naphthalene, 1,2,3,4,4*α*,7-hexahydro-1,6-dimethyl-4-(1-methylethyl)-   MS, RI   16728-99-7   0.29                     0.25    0.17
  47    1541    *α-*Cadinene                                                            MS, RI   24406-05-1   0.49                     0.39    0.27
  48    1552    Calacorene                                                              MS, RI   38599-17-6   0.2                      0.16    ---
  49    1561    *trans-*Nerolidol                                                       MS, RI   40716-66-3   4.03                     9.9     3.58
  50    1572    (−)-Spathulenol                                                         MS, RI   77171-55-2   0.47                     1.14    0.63
  51    1583    Globulol                                                                MS, RI   51371-47-2   0.42                     0.38    ---
  52    1600    Viridiflorol                                                            MS, RI   552-02-3     0.55                     0.37    ---
  53    1620    *β-*Eudesmol                                                            MS, RI   473-15-4     0.24                     0.29    ---
  54    1641    Cubenol                                                                 MS, RI   21284-22-0   0.67                     1.29    ---
  55    1647    Selina-6-en-4-ol                                                        MS, RI   1461-03-6    0.32                     0.52    ---
  56    1654    *τ-*Candinol                                                            MS, RI   5937-11-1    0.56                     ---     ---
  57    1661    *τ-*Muurolol                                                            MS, RI   19912-62-0   1.47                     2.14    1
  58    1668    *α*-Cadinol                                                             MS, RI   481-34-5     2.61                     2.29    1.06
  59    1683    Ledene oxide-(II)                                                       MS       NA^d^        0.17                     ---     0.24
  60    1730    5,6,6-Trimethyl-5-(3-oxobut-1-enyl)-1-oxaspiro\[2.5\]octan-4-one        MS       NA^d^        0.08                     0.15    ---
  61    1840    Cyclopentadecanone, 2-hydroxy-                                          MS, RI   4727-18-8    0.08                     ---     ---
  62    1857    Pentadecanoic acid                                                      MS, RI   1002-84-2    0.22                     0.3     ---
  63    1923    1,3,6,10-Cyclotetradecatetraene                                         MS, RI   1898-13-1    0.53                     0.75    0.85
  64    1927    Kaur-16-ene, (8*β*,13*β*)-                                              MS       20070-61-5   0.41                     0.61    0.62
  65    1933    Hexadecanoic acid, methyl ester                                         MS, RI   112-39-0     0.63                     0.53    0.9
  66    1946    2,6,8,10,14-Hexadecapentaene, 2,6,11,15-tetramethyl-, (E,E,E)-          MS       38259-79-9   6.54                     8.49    11.21
  67    1975    Hexadecanoic acid                                                       MS, RI   57.10.3      4.79                     0.07    11.7
  68    2008    Geranyl linalool                                                        MS, RI   1113-21-9    3.54                     3.31    4.27
  69    2023    Bergapten                                                               MS, RI   484-20-8     0.13                     ---     1.33
  70    2079    Methyl linoleate                                                        MS, RI   112-63-0     0.31                     0.13    0.47
  71    2102    Methyl linolenate                                                       MS, RI   301-00-8     0.44                     0.2     ---
  72    2139    Osthole                                                                 MS, RI   484-12-8     0.03                     ---     0.53
  73    2150    Z,Z-10,12-Hexadecadien-1-ol acetate                                     MS, RI   60-33-3      1.53                     ---     3.12
  74    2158    *α-*Linolenic acid                                                      MS, RI   463-40-1     1.56                     ---     4.14
  75    2177    Ethyl linoleate                                                         MS, RI   7619-08-1    0.11                     ---     ---
  76    ---     *α-*Glyceryl linolenate                                                 MS       18465-99-1   0.16                     ---     0.84
  77    ---     Isogeijerin                                                             MS       38409-25-5   ---                      ---     5.21
  78    ---     3-Ethyl-5-(2-ethylbutyl)-octadecane                                     MS       55282-12-7   0.06                     ---     ---
  79    ---     Heptadecane, 9-hexyl-                                                   MS       55124-79-3   0.07                     ---     ---
  80    ---     2,2′-Methylenebis(6-tert-butyl-*p*-cresol)                              MS       119-47-1     0.04                     ---     1.13
  81    ---     Auraptene                                                               MS       495-02-3     0.06                     ---     2.41

^a^Retention indices were calculated using a homologous series of *n*-alkanes (C~7~--C~22~).

^b^Identification of volatile compounds was carried out by comparing MS spectrum and RIs of components in ECG with those of the authentic standards in NIST library (2005) and previous study. In the comparison of MS spectrum, the requisites should be that both SI and RSI were more than 800.

^c^Results obtained by peak-area normalization.

^d^NA: not available.

###### 

Comparison of extraction parameters among the three extraction methods for volatiles from ECG.

                          SD      HS-SPME   SE
  ----------------------- ------- --------- ---------------
  Extraction time (min)   300     40        45
  Solvent                 Water   ---       Diethyl ether
  Solvent volume (mL)     300     None      90 (30∗3)
  Material amount (g)     36      0.2       3
  Yield (%)               0.89    NA^a^     3.67
  Cost ^b^                ++      +++       \+

^a^Not available.

^b^The degrees of the economic cost were expressed by "+".

[^1]: Academic Editor: David Bongiorno
